Dr. Rob Shimizu brings over 35 years of corporate experience in ophthalmology ranging from research to development of pharmaceuticals, ocular devices, and combination products for diseases in both the anterior and posterior segments of the eye.  Rob has successfully led multinational—interdisciplinary teams through regulatory activities leading to approvals in North America, the EU, and Asia.
Blog Categories
Disciplines